Search research articles
Contact Us
Filters
Showing results (11-20 of 55) with videos related to
Page
of 6
Sort By:
Nature Methods
|
August 14, 2012
Fractional proliferation: a method to deconvolve cell population dynamics from single-cell data
Darren R Tyson, Shawn P Garbett, Peter L Frick, et al.
Biorxiv : the Preprint Server for Biology
|
November 14, 2023
Purinergic Ca<sup>2+</sup> signaling as a novel mechanism of drug tolerance in BRAF mutant melanoma
Philip E Stauffer, Jordon Brinkley, David Jacobson, et al.
The Prostate
|
August 21, 2007
Culture requirements of prostatic epithelial cell lines for acinar morphogenesis and lumen formation in vitro: role of extracellular calcium
Darren R Tyson, Junichi Inokuchi, Toshiyuki Tsunoda, et al.
Endocrinology
|
January 18, 2002
PTH induction of transcriptional activity of the cAMP response element-binding protein requires the serine 129 site and glycogen synthase kinase-3 activity, but not casein kinase II sites
Darren R Tyson, John T Swarthout, Stephen C Jefcoat, et al.
Plos One
|
February 13, 2018
A drift-diffusion checkpoint model predicts a highly variable and growth-factor-sensitive portion of the cell cycle G1 phase
Zack W Jones, Rachel Leander, Vito Quaranta, et al.
Journal of Theoretical Biology
|
July 17, 2012
The contribution of age structure to cell population responses to targeted therapeutics
Pierre Gabriel, Shawn P Garbett, Vito Quaranta, et al.
Cancers
|
July 13, 2024
Purinergic Ca<sup>2+</sup> Signaling as a Novel Mechanism of Drug Tolerance in BRAF-Mutant Melanoma
Philip E Stauffer, Jordon Brinkley, David A Jacobson, et al.
The Prostate
|
June 3, 2006
The impact of altered annexin I protein levels on apoptosis and signal transduction pathways in prostate cancer cells
Chin-Hui Hsiang, Toshiyuki Tunoda, Young E Whang, et al.
JAMA Otolaryngology-- Head & Neck Surgery
|
April 10, 2015
Response of head and neck squamous cell carcinoma cells carrying PIK3CA mutations to selected targeted therapies
Eric D Wirtz, Daisuke Hoshino, Anthony T Maldonado, et al.
Cancer Biology & Therapy
|
April 21, 2022
Real-time luminescence enables continuous drug-response analysis in adherent and suspension cell lines
Clayton M Wandishin, Charles John Robbins, Darren R Tyson, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 55) with videos related to
Sort By:
Page
of 6
Nature Methods
|
August 14, 2012
Fractional proliferation: a method to deconvolve cell population dynamics from single-cell data
Darren R Tyson, Shawn P Garbett, Peter L Frick, et al.
Biorxiv : the Preprint Server for Biology
|
November 14, 2023
Purinergic Ca<sup>2+</sup> signaling as a novel mechanism of drug tolerance in BRAF mutant melanoma
Philip E Stauffer, Jordon Brinkley, David Jacobson, et al.
The Prostate
|
August 21, 2007
Culture requirements of prostatic epithelial cell lines for acinar morphogenesis and lumen formation in vitro: role of extracellular calcium
Darren R Tyson, Junichi Inokuchi, Toshiyuki Tsunoda, et al.
Endocrinology
|
January 18, 2002
PTH induction of transcriptional activity of the cAMP response element-binding protein requires the serine 129 site and glycogen synthase kinase-3 activity, but not casein kinase II sites
Darren R Tyson, John T Swarthout, Stephen C Jefcoat, et al.
Plos One
|
February 13, 2018
A drift-diffusion checkpoint model predicts a highly variable and growth-factor-sensitive portion of the cell cycle G1 phase
Zack W Jones, Rachel Leander, Vito Quaranta, et al.
Journal of Theoretical Biology
|
July 17, 2012
The contribution of age structure to cell population responses to targeted therapeutics
Pierre Gabriel, Shawn P Garbett, Vito Quaranta, et al.
Cancers
|
July 13, 2024
Purinergic Ca<sup>2+</sup> Signaling as a Novel Mechanism of Drug Tolerance in BRAF-Mutant Melanoma
Philip E Stauffer, Jordon Brinkley, David A Jacobson, et al.
The Prostate
|
June 3, 2006
The impact of altered annexin I protein levels on apoptosis and signal transduction pathways in prostate cancer cells
Chin-Hui Hsiang, Toshiyuki Tunoda, Young E Whang, et al.
JAMA Otolaryngology-- Head & Neck Surgery
|
April 10, 2015
Response of head and neck squamous cell carcinoma cells carrying PIK3CA mutations to selected targeted therapies
Eric D Wirtz, Daisuke Hoshino, Anthony T Maldonado, et al.
Cancer Biology & Therapy
|
April 21, 2022
Real-time luminescence enables continuous drug-response analysis in adherent and suspension cell lines
Clayton M Wandishin, Charles John Robbins, Darren R Tyson, et al.
Page
of 6